[Federal Register Volume 84, Number 99 (Wednesday, May 22, 2019)]
[Notices]
[Pages 23582-23583]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-10668]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Application: United States
Pharmacopeial Convention
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before June 21, 2019. Such
persons may also file a written request for a hearing on the
application on or before June 21, 2019.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
request for a hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Assistant Administrator of the DEA Diversion Control Division
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0,
appendix to subpart R.
In accordance with 21 CFR 1301.34(a), this is notice that on March
8, 2019, United States Pharmacopeial, 12601 Twinbrook Parkway,
Rockville, Maryland 20852-1717 applied to be registered as an importer
of the following basic classes of controlled substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Methamphetamine.......................... 1105 II
Cathinone................................ 1235 I
Phenmetrazine............................ 1631 II
Methylphenidate.......................... 1724 II
Amobarbital.............................. 2125 II
Pentobarbital............................ 2270 II
Secobarbital............................. 2315 II
Glutethimide............................. 2550 II
Methaqualone............................. 2565 I
Lysergic acid diethylamide............... 7315 I
4-Methyl-2,5-dimethoxyamphetamine........ 7395 I
3,4-Methylenedioxyamphetamine............ 7400 I
4-Methoxyamphetamine..................... 7411 I
Phencyclidine............................ 7471 II
4-Anilino-N-phenethyl-4-piperidine (ANPP) 8333 II
Phenylacetone............................ 8501 II
Alphaprodine............................. 9010 II
Anileridine.............................. 9020 II
Cocaine.................................. 9041 II
Codeine-N-oxide.......................... 9053 I
Dihydrocodeine........................... 9120 II
Difenoxin................................ 9168 I
Diphenoxylate............................ 9170 II
Heroin................................... 9200 I
Levomethorphan........................... 9210 II
Levorphanol.............................. 9220 II
Meperidine............................... 9230 II
Dextropropoxyphene, bulk (non-dosage 9273 II
forms).
[[Page 23583]]
Morphine-N-oxide......................... 9307 I
Thebaine................................. 9333 II
Norlevorphanol........................... 9634 II
Oxymorphone.............................. 9652 II
Noroxymorphone........................... 9668 II
Alfentanil............................... 9737 II
Sufentanil............................... 9740 II
------------------------------------------------------------------------
The company plans to import the bulk control substances for
distribution of analytical reference standards to its customers for
analytical testing of raw materials.
Dated: May 7, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019-10668 Filed 5-21-19; 8:45 am]
BILLING CODE 4410-09-P